Liver Diseases presents state-of-the-art information summarizing the current understanding of a range of liver diseases, and reviews some key diagnostic and therapeutic advances.
Features:
- Treats the cellular, biochemical and immunological mechanisms underlying liver diseases
- Focuses on clinical liver disease pathophysiology and related diagnostics and therapeutic insights
- Targets hepatologists, clinicians, researchers and cademicians
Contents
Volume 1: Liver Diseases: Pathways, Mediators and Regulation
Liver Diseases: Mediators and Regulation
- Ubiquitin - Proteasome Pathway in the Pathogenesis of Liver Disease
- Bardag-Gorce
- Collagen Gene Regulation in the Hepatic Stellate Cell
- CYP2F1-Biochemical and Toxicological Aspects and Role in Alcohol-induced Liver Injury
- Alcohol and Methyl Transfer: Implications for Alcohol-Related Hepatocarcinogenesis
- Menthionine Adenosyltransferase and S-adenosylmethionine in Liver Health and Disease
- Acetone Metabolism in the Liver
- Oxidative Stress and Liver Fibrosis: From Liver Injury to Modulation of Cell Signalling and Response
- Role of Nitric Oxide in Liver Disorders
- Renin-Angiotensin System in Liver Fibrosis
Immunological Basis of Liver Injury
- Cell and Molecular Mechanisms in the Development of Chronic Liver Inflammation
- Role of Activated Macrophages in Liver Disease
- Investigations into Basis for Immune Recognition of Cellular Targets in Primary Biliary Cirrhosis
- Cross Talk of Hepatocytes and Nonparenchymal Liver Cells in Physiology and Pathology
- Monoxides and Eicosanoids
- Activity of Cytokines in Chronic HCV Infection and
- Influence of Antiviral Drugs
- Role of Chemokines in Liver Pathophysiology
Volume 2: Clinical Liver Diseases: Pathophysiology, Diagnostic and Therapeutic Insights
Clinical Liver Disease Pathophysiology
- Nonalcoholic Fatty Liver Diseases
- Clinical and Pathophysiological Features
- Genetic Basis of Hepatocellular Cancer
- Haemochromatosis
- Recent Advances
- Pathophysiology of Cirrhotic Ascites
- Cryptogenic Hepatitis
- HIV-1 and the Liver
- Cell Death by Necrosis
- Mechanisms and Interception in the Liver
- Fulminant Hepatic Failure: Etiology, Pathogenesis, and Treatment
Therapeutic and Diagnostic Insights
- Advances in Biology and Therapy of Hepatitis B Virus Infection
- Hepatitis C Virus
- Molecular Virology and Therapeutic Targets
- Drug Targeting to
Hepatic Stellate Cells
- A New Strategy to Treat Liver Fibrosis
- Developing
Therapeutic Strategies for Hepatic Fibrosis
- Liver Disease, Oxidative Stress and
Ursodeoxycholic Acid
- Plasma TGF-b as a Diagnostic and
Prognostic Marker
- Hepatocytes as the Gold Standard for Predicting in-vivo
Hepatotoxicity of Xenobiotics Using Accelerated Cytotoxicity Mechanism Screening Techniques
Index